BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 34257795)

  • 1. Nationwide pharmacovigilance data for cetuximab-induced anaphylaxis and predictive model validation using prospective specific IgE detection.
    Park KH; Lee J; Beom SH; Shin SJ; Ahn JB; Kim SR; Lee JH; Park JW
    World Allergy Organ J; 2021 Jul; 14(7):100553. PubMed ID: 34257795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alpha-Gal-containing biologics and anaphylaxis.
    Chinuki Y; Morita E
    Allergol Int; 2019 Jul; 68(3):296-300. PubMed ID: 31053502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of an anti-α-Gal IgE fluoroenzyme-immunoassay for the screening of patients at risk of severe anaphylaxis to cetuximab.
    Serrier J; Davy JB; Dupont B; Clarisse B; Parienti JJ; Petit G; Khoy K; Ollivier Y; Gervais R; Mariotte D; Le Mauff B
    BMC Cancer; 2023 Jan; 23(1):32. PubMed ID: 36624467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alpha-gal is a possible target of IgE-mediated reactivity to antivenom.
    Fischer J; Eberlein B; Hilger C; Eyer F; Eyerich S; Ollert M; Biedermann T
    Allergy; 2017 May; 72(5):764-771. PubMed ID: 27775867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fatal anaphylaxis due to alpha-gal syndrome after initial cetuximab administration: The first forensic case report.
    Wen S; Unuma K; Chinuki Y; Hikino H; Uemura K
    Leg Med (Tokyo); 2021 Jul; 51():101878. PubMed ID: 33892262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Skin prick test and basophil reactivity to cetuximab in patients with IgE to alpha-gal and allergy to red meat.
    Michel S; Scherer K; Heijnen IA; Bircher AJ
    Allergy; 2014 Mar; 69(3):403-5. PubMed ID: 24372137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased rates of cetuximab reactions in tick prevalent regions and a proposed protocol for risk mitigation.
    Yuile A; Fanuli C; van Nunen S; Diakos C; Clarke S; Steiner C; MacMillan R; Oatley M; Pavlakis N
    Asia Pac J Clin Oncol; 2021 Dec; 17(6):448-453. PubMed ID: 32970939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug allergens and food--the cetuximab and galactose-α-1,3-galactose story.
    Berg EA; Platts-Mills TA; Commins SP
    Ann Allergy Asthma Immunol; 2014 Feb; 112(2):97-101. PubMed ID: 24468247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meat allergy associated with galactosyl-α-(1,3)-galactose (α-Gal)-Closing diagnostic gaps by anti-α-Gal IgE immune profiling.
    Jappe U; Minge S; Kreft B; Ludwig A; Przybilla B; Walker A; Varga R; Seidel P; Biedermann T; Anemüller W; Kromminga A; Ruëff F; Merk H; Wagner N; Treudler R; Worm M; Waldmann I; Saloga J; Becker WM; Goldmann T; Platts-Mills TA; Homann A
    Allergy; 2018 Jan; 73(1):93-105. PubMed ID: 28670695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accurate assessment of alpha-gal syndrome using cetuximab and bovine thyroglobulin-specific IgE.
    Sim DW; Lee JS; Park KH; Jeong KY; Ye YM; Lee JH; Park JW
    Mol Nutr Food Res; 2017 Oct; 61(10):. PubMed ID: 28497612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cetuximab-induced anaphylaxis and IgE specific for galactose-alpha-1,3-galactose.
    Chung CH; Mirakhur B; Chan E; Le QT; Berlin J; Morse M; Murphy BA; Satinover SM; Hosen J; Mauro D; Slebos RJ; Zhou Q; Gold D; Hatley T; Hicklin DJ; Platts-Mills TA
    N Engl J Med; 2008 Mar; 358(11):1109-17. PubMed ID: 18337601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-cetuximab IgE ELISA for identification of patients at a high risk of cetuximab-induced anaphylaxis.
    Mariotte D; Dupont B; Gervais R; Galais MP; Laroche D; Tranchant A; Comby E; Bouhier-Leporrier K; Reimund JM; Le Mauff B
    MAbs; 2011; 3(4):396-401. PubMed ID: 21654207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anaphylaxis to the carbohydrate side chain alpha-gal.
    Platts-Mills TA; Schuyler AJ; Tripathi A; Commins SP
    Immunol Allergy Clin North Am; 2015 May; 35(2):247-60. PubMed ID: 25841549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel approach to predict cetuximab-induced hypersensitivity reaction: detection of drug-specific IgE on basophils.
    Iwamoto T; Okamoto A; Ishinaga H; Shimizu K; Gayle AA; Arai N; Takeuchi K; Okuda M
    Cancer Med; 2016 Jun; 5(6):1004-12. PubMed ID: 26880699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Update on meat allergy. α-Gal: a new epitope, a new entity?].
    Jappe U
    Hautarzt; 2012 Apr; 63(4):299-306. PubMed ID: 22418768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using the galactose-α-1,3-galactose enzyme-linked immunosorbent assay to predict anaphylaxis in response to cetuximab.
    Weiss J; Grilley Olson J; Deal AM; Chera B; Weissler M; Murphy BA; Hayes DN; Gilbert J
    Cancer; 2016 Jun; 122(11):1697-701. PubMed ID: 26989991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two galactose-α-1,3-galactose carrying peptidases from pork kidney mediate anaphylactogenic responses in delayed meat allergy.
    Hilger C; Fischer J; Swiontek K; Hentges F; Lehners C; Eberlein B; Morisset M; Biedermann T; Ollert M
    Allergy; 2016 May; 71(5):711-9. PubMed ID: 26728983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac Arrest Induced by an Anaphylactic Reaction Associated With the First Dose of Cetuximab.
    Hane A; Ito A; Ishikura K; Imai H; Okugawa Y
    Cureus; 2022 Jun; 14(6):e26351. PubMed ID: 35903575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Children with wheat anaphylaxis and with low wheat specific IgE have a different IgE immunoblot pattern than those with high wheat specific IgE.
    Rutrakool N; Piboonpocanun S; Wangthan U; Srisuwatchari W; Thongngarm T; Jirapongsananuruk O; Visitsunthorn N; Vichyanond P; Pacharn P
    Asian Pac J Allergy Immunol; 2023 Feb; ():. PubMed ID: 36773279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of serum anti-cetuximab immunoglobulin E levels to identify patients at a high risk of severe hypersensitivity reaction to cetuximab.
    Dupont B; Mariotte D; Dugué AE; Clarisse B; Grellard JM; Babin E; Chauffert B; Dakpé S; Moldovan C; Bouhier-Leporrier K; Reimund JM; Di Fiore F; Zanetta S; Mailliez A; Do P; Peytier A; Galais MP; Florescu C; Schott R; Le Mauff B; Gervais R
    Br J Clin Pharmacol; 2017 Mar; 83(3):623-631. PubMed ID: 27662818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.